Development Level
Tclin | 350 | 130,166 | |
Tchem | 77 | 105,938 |
Target Family
GPCR | 303 | 59,407 | |
Ion Channel | 62 | 16,788 | |
Non-IDG | 34 | 16,175 | |
Transporter | 32 | 9,204 | |
Enzyme | 23 | 85,645 | |
Nuclear Receptor | 17 | 7,246 |
Target
HRH1 | 75 | 553 | |
DRD2 | 61 | 2,432 | |
HTR2A | 59 | 2,122 | |
CHRM1 | 47 | 640 | |
CHRM3 | 44 | 950 | |
CHRM4 | 32 | 263 | |
ADRA1D | 31 | 728 | |
DRD3 | 31 | 2,406 | |
HTR2C | 29 | 1,221 | |
ADRB1 | 28 | 291 | |
CHRM2 | 28 | 688 | |
KCNH2 | 28 | 4,432 | |
CHRM5 | 27 | 171 | |
ADRA1A | 23 | 1,054 | |
HTR2B | 23 | 551 | |
HTR6 | 23 | 2,009 | |
HTR7 | 22 | 976 | |
SIGMAR1 | 22 | 1,854 | |
ADRB2 | 19 | 394 | |
ADRA1B | 18 | 583 | |
ADRA2B | 18 | 185 | |
ADRA2C | 18 | 306 | |
HTR1A | 18 | 2,209 | |
SLC6A4 | 18 | 3,433 | |
ADRA2A | 16 | 389 | |
DRD4 | 16 | 1,320 | |
DRD1 | 13 | 450 | |
HTR1B | 13 | 574 | |
SLC6A2 | 13 | 2,227 | |
CHRNA1 | 12 | 23 | |
HTR3A | 12 | 432 | |
OPRM1 | 12 | 1,833 | |
AGTR1 | 11 | 563 | |
CHRNB1 | 11 | 13 | |
CHRND | 11 | 18 | |
ADORA3 | 10 | 1,774 | |
HTR1D | 10 | 824 | |
HTR1E | 10 | 39 | |
HTR1F | 10 | 127 | |
OPRK1 | 8 | 1,683 | |
SLC6A3 | 8 | 1,766 | |
AR | 7 | 796 | |
CYP2D6 | 7 | 45 | |
HRH2 | 7 | 43 | |
OPRD1 | 7 | 1,607 | |
ADORA2B | 6 | 900 | |
EDNRA | 6 | 716 | |
ADORA1 | 5 | 1,178 | |
ADORA2A | 5 | 1,585 | |
CYP2C19 | 5 | 41 | |
DRD5 | 5 | 116 | |
HTR5A | 5 | 122 | |
P2RY12 | 5 | 641 | |
TACR1 | 5 | 1,853 | |
ADRB3 | 4 | 240 | |
AVPR1A | 4 | 409 | |
CYSLTR1 | 4 | 105 | |
GNRHR | 4 | 760 | |
HTR3B | 4 | 6 | |
NR3C2 | 4 | 175 | |
PGR | 4 | 640 | |
ACHE | 3 | 1,877 | |
AGTR2 | 3 | 256 | |
AVPR2 | 3 | 311 | |
CA12 | 3 | 2,010 | |
CA2 | 3 | 4,185 | |
CA7 | 3 | 452 | |
EDNRB | 3 | 207 | |
EPHX2 | 3 | 1,376 | |
ESR1 | 3 | 967 | |
ESR2 | 3 | 923 | |
KCNK2 | 3 | 20 | |
PDE3A | 3 | 134 | |
PDE4A | 3 | 523 | |
PDE4B | 3 | 813 | |
SCN5A | 3 | 327 | |
SLC47A1 | 3 | 16 | |
ABCB1 | 2 | 570 | |
AVPR1B | 2 | 105 | |
CA1 | 2 | 2,654 | |
CA5A | 2 | 138 | |
CA6 | 2 | 99 | |
CA9 | 2 | 2,402 | |
CHRFAM7A | 2 | 455 | |
CHRNA3 | 2 | 22 | |
EBP | 2 | 43 | |
ESRRA | 2 | 31 | |
GABRA1 | 2 | 147 | |
GLRA1 | 2 | 45 | |
GRIA4 | 2 | 40 | |
GRIN2A | 2 | 6 | |
HCRTR1 | 2 | 542 | |
HCRTR2 | 2 | 854 | |
KCNH1 | 2 | 14 | |
KCNJ6 | 2 | 14 | |
NR3C1 | 2 | 1,509 | |
PDE4C | 2 | 87 | |
PDE4D | 2 | 442 | |
SCN1A | 2 | 51 | |
TLR7 | 2 | 47 |
Pharmalogical Action
ANTAGONIST | 350 | 350 | |
INHIBITOR | 542 | 542 | |
AGONIST | 427 | 427 | |
BLOCKER | 129 | 129 | |
ANTIBODY BINDING | 57 | 57 | |
POSITIVE ALLOSTERIC MODULATOR | 51 | 51 | |
ACTIVATOR | 30 | 30 | |
MODULATOR | 20 | 20 | |
OPENER | 16 | 16 | |
POSITIVE MODULATOR | 15 | 15 | |
PARTIAL AGONIST | 14 | 14 | |
INVERSE AGONIST | 9 | 9 | |
GATING INHIBITOR | 6 | 6 | |
NEGATIVE ALLOSTERIC MODULATOR | 5 | 5 | |
RELEASING AGENT | 5 | 5 | |
SUBSTRATE | 5 | 5 | |
ALLOSTERIC MODULATOR | 4 | 4 | |
PHARMACOLOGICAL CHAPERONE | 3 | 3 | |
ALLOSTERIC ANTAGONIST | 2 | 2 | |
OTHER | 1 | 1 |
Ligand Activity
Ki | 128 | 70,819 | |
IC50 | 100 | 143,077 | |
- | 29 | 698 | |
EC50 | 11 | 8,212 | |
Kd | 8 | 2,908 |
Ligand Activity Source
ChEMBL | 124 | 220,950 | |
Guide to Pharmacology | 86 | 5,022 |
Ligand Source
CHEMBL | 247 | 221,632 | |
Guide to Pharmacology | 86 | 5,022 | |
SCIENTIFIC LITERATURE | 51 | 269 | |
IUPHAR | 40 | 129 | |
DRUG LABEL | 33 | 243 | |
KEGG DRUG | 13 | 45 |
-
topiramate
Tclin
-
rolapitant
Tclin
-
netupitant
Tclin
-
fosaprepitant
Tclin
-
aprepitant
Tclin
-
casopitant
Tclin
-
vorapaxar
Tclin
-
bosentan
Tclin
-
macitentan
Tclin
-
terazosin
Tclin
-
dapiprazole
Tclin
-
urapidil
Tclin
-
alfuzosin
Tclin
-
naftopidil
Tclin
-
alfuzosin
Tclin
-
cyproheptadine
Tchem Tclin
-
dapiprazole
Tclin
-
doxazosin
Tclin
-
labetalol
Tclin
-
silodosin
Tclin